LUPUS. and Medication LUPUSUK 2015

Similar documents
LUPUS. The Skin and Hair LUPUSUK 2015

and the Brain Published by Reg. Charity Nos , SC LUPUS UK.

LUPUS. The Mouth, Nose and Eyes LUPUSUK 2018

LUPUS. and Associated Conditions LUPUSUK 2015

LUPUS. and Associated Conditions LUPUSUK 2018

Lupus. and the Kidneys

The Diagnosis of Lupus

13. Behçet s - In Children

Lupus. Fast facts. What is lupus? What causes lupus? Who gets lupus?

Systemic Lupus Erythematosus

Helpline No:

PACKAGE LEAFLET: INFORMATION FOR THE USER. EASOFEN MAX STRENGTH 400mg FILM-COATED TABLETS. Ibuprofen

Arthritis & Rheumatology Clinics of Kansas PATIENT EDUCATION SYSTEMIC LUPUS ERYTHEMATOSUS

Use of steroids in neurological conditions. Information for patients Pharmacy

Learning about Lupus. Learning About Lupus. Lupus Society of Illinois

Information on Azathioprine for Inflammatory Bowel Disease

PATIENT INFORMATION LEAFLET. Nu-Seals 75 aspirin (acetylsalicylic acid)

Drug information. Sarilumab SARILUMAB. is used to treat rheumatoid arthritis. Helpline

Elements for a Public Summary Overview of disease epidemiology

PACKAGE LEAFLET: INFORMATION FOR THE USER. Raloxifen STADA 60 mg film-coated tablets (raloxifene hydrochloride)

Summary Article: Lupus (Systemic Lupus Erythematosus) from Harvard Medical School Health Topics A-Z

Mycophenolate mofetil: risks of miscarriage and birth defects. Patient guide

Methotrexate for inflammatory bowel disease: what you need to know

Mycophenolate mofetil (MMF) for Myasthenia

Tocilizumab Tocilizumab

If your IBD has not been well controlled, or is flaring up quite often, methotrexate may be added to your treatment.

National Neuromyelitis Optica Service

MEDICATIONS: THE GOOD, THE BAD, THE UGLY

Deep Vein Thrombosis

Immune system not suppressed and therefore no increased susceptibility to infections

Package leaflet: Information for the patient. Acetylsalicylic acid Bluefish 75 mg tablets Acetylsalicylic acid Bluefish 160 mg tablets

DRUG THERAPY

Department of Clinical Haematology. Chemotherapy. Information for patients. Page 1 of 12

Mycophenolate treatment for respiratory conditions. Information for patients Respiratory Medicine - Asthma

Pain relief after caesarean section. Information for patients Royal Hallamshire Hospital, Jessop Wing

Patient Information Leaflet Lodine* SR Tablets 600mg (etodolac) 1. WHAT LODINE SR TABLETS ARE AND WHAT THEY ARE USED FOR

Methotrexate. Information for patients. Paediatric Rheumatology. Feedback

FACTSHEET CICLOSPORIN. Introduction. How does ciclosporin work? When is ciclosporin used?

4. Behçet s - Treatment

UNDERSTANDING SYSTEMIC LUPUS ERYTHEMATOSUS

Corporate Medical Policy

What is this leaflet about?

Neuropsychiatric Systemic Lupus Erythematosus (NPSLE) Case presentations and topic discussion The Rheumatology Unit UMMC experience

Definition Chronic autoimmune disease The body s immune system starts attacking itself Can affect most organs and tissues in the body Brain, lungs, he

9/25/2013 SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

Immune Thrombocytopenia (ITP)

NEXIUM INTRAVENOUS esomeprazole sodium

Modified Ponticelli treatment record card

Prophylaxis of acute transplant rejection in patients receiving allogeneic renal transplants:

Disease modifying drugs. a guide to Mavenclad

Polycystic Ovary Syndrome

Hydroxychloroquine. Drug information Hydroxychloroquine

Infliximab Drug information. Infliximab can treat rheumatoid arthritis and psoriatic arthritis.

Package leaflet: Important information for the patient. Dexamethasone 2mg Tablets Dexamethasone

For the Patient: CAP. Capecitabine. Uses:

Liver Health: Do you have liver problems? Yes No If so, please specify:

Non-steroidal Anti-Inflammatory Drugs (NSAIDs)

Drug information. Tofacitinib TOFACITINIB. is used to treat rheumatoid arthritis and psoriatic arthritis. Helpline

Immune Thrombocytopenic Purpura (ITP)

SULFASALAZIN 500mg enteric-coated tablets

LUPUS AND LUPUS KIDNEY DISEASE

Azathioprine. Drug information. Azathioprine is used to treat rheumatoid arthritis, lupus and other conditions.

PRODUCT MONOGRAPH. FLOCTAFENINE Floctafenine Tablets 200 mg and 400 mg THERAPEUTIC CLASSIFICATION. Anti-inflammatory, Analgesic

Methotrexate in Inflammatory Bowel Disease. An information guide

Leflunomide Treatment Rheumatology Patient Information Leaflet

Methotrexate. You will have a routine blood test before the start of each cycle of treatment.

After a kidney transplant

Rheumatology Department Patient Information Leaflet

Haematology. C = Cyclophosphamide (pronounced sigh clo fos fa mide)

Package Leaflet: Information for the User. Read all of this leaflet carefully because it contains important information for you.

Drug information. Baricitinib BARICITINIB. is used to treat rheumatoid arthritis. Helpline

Venous Thromboembolic Events (VTEs)

Preventing blood clots while you are in hospital and after you leave. Information for patients Pharmacy

Dexamethasone is used to treat cancer. This drug can be given in the vein (IV), by mouth, or as an eye drop.

How to prevent blood clots whilst in hospital and after your return home

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM CYTARABINE (HIGH DOSE)

Etopan XL 600 mg tablets

Methotrexate Methotrexate.indd 1 9/1/16 11:40 AM

Cardiff & Vale (C&V) UHB Corporate Medicines Management Group (c MMG) SHARED CARE. Drug: MYCOPHENOLATE MOFETIL/SODIUM Protocol number: CV 15

Women and epilepsy. Introduction. Puberty and young women

Irbenida H 150mg/12,5mg film-coated tablets

stroke.org.uk Atrial Fibrillation Reducing your risk of stroke

Venous Thrombo-Embolism (VTE)

Medication information for patients and families

Polycystic Ovary Syndrome

Drug information. Belimumab BELIMUMAB. is used to treat lupus (SLE) Helpline

SYSTEMIC LUPUS ERYTHEMATOSUS: CURRENT CONCEPTS AND CLINICAL PEARLS. Dr Sheila Vasoo Consultant Division of Rheumatology NUHS

For the Patient: LUAVPP (Carboplatin Option)

A patient guide to membranous nephropathy

Hospital No. Weston Park Hospital contact number

NALGESIN NALGESIN S 275 mg Film-coated tablets NALGESIN F 500 mg Film-coated tablets

Welcome to About Women by Women

Cellcept. Eye Clinic Tel:

Confirmed blood clot

Nilotinib (nil ot' i nib) is a drug that is used to treat some types of cancer. It is a capsule that you take by mouth.

Capecitabine chemotherapy and concurrent radiotherapy to the pancreas

TOFACITINIB PATIENT INFORMATION ON. (Brand name: Xeljanz ) What is tofacitinib? Important things to remember

Doncaster & Bassetlaw Medicines Formulary

Patient Information Leaflet UNITED KINGDOM Feldene IM Intramuscular Injection 20mg/ml piroxicam

Cardiff & Vale (C&V) UHB Corporate Medicines Management Group (c MMG) SHARED CARE. Drug: AZATHIOPRINE Protocol number: CV 04

Transcription:

9 LUPUS and Medication LUPUSUK 2015

LUPUS and Medication The types of drugs used in lupus can be broadly divided into those that treat the disease itself (e.g. hydroxychloroquine and prednisolone) and those that are used for other problems sometimes associated with lupus (e.g. tablets for high blood pressure). Non-steroidal anti-inflammatory drugs (NSAIDS) These are the standard drugs used for joint pains such as ibuprofen (Nurofen). There are many types and they are designed to reduce pain due to inflammation. They are used most for arthritis and pleurisy. Unfortunately, they are prone to cause indigestion. They may cause peptic ulcers and bleeding from the gut and may increase the risk of heart attacks and stroke if taken regularly for long periods of time (e.g. years). Anti-malarials The most commonly used drug in this group is hydroxychloroquine. It has a number of properties which make it useful in treating lupus, for example disease modifying properties resulting in reduction in fatigue, sun-induced flares and flares of arthritis, pleurisy, fever and it is safe in pregnancy and breast-feeding. There is some evidence that it may reduce blood clotting (sticky blood) and it improves the outcome for mother and baby if taken in pregnancy. The older drug chloroquine was associated with a higher risk of eye (retinal) damage so it is avoided now. Recent studies

with hydroxychloroquine, at recommended doses based on body weight, show that the risk of retinal disease is minimal. Unfortunately, hydroxychloroquine may take 3-6 months to exert its full effect and it is not sufficient for treating severe lupus manifestations such as kidney disease and nervous system involvement. Corticosteroids (eg prednisolone) These are life-saving for moderate and severe lupus (e.g. kidney, lung, heart, gut and nervous system) and have totally changed the outcome of the disease. Modern treatment is geared to reduce the dose as soon as possible, and it is now known that the majority of lupus patients can be maintained either on a low dose or be weaned off steroids altogether. The side-effects of high dose steroids long term are well known and include weight gain and moon face, diabetes, infections, raised cholesterol, muscle weakness and bone softening or osteoporosis. The risks are highest with higher doses for longer periods of time. Injections intramuscularly or intravenously may provide an alternative to high dose daily steroids to treat severe manifestations of lupus quickly with the least risk of side-effects. Immunosuppressives These drugs are used to reduce the need for steroids to control moderate and severe lupus. Azathioprine is a milder immunosuppressive and is safe in pregnancy after appropriate counselling. It is used when it is difficult to reduce the steroid dosage. Methotrexate is an alternative but it is not suitable for patients with kidney disease or those wanting to become pregnant. Cyclophosphamide is given as an injection or pulse and is widely used for severe kidney disease and severe neuropsychiatric disease. It is a very effective drug and the newer regimes using lower doses by injection have a much higher safety profile than the older higher dose regimes. Possible side-effects of cyclophosphamide are a reduction in white cell count with risk of infections and with the use of higher

doses, failure of the ovaries or sperm-producing cells, making the patient infertile (unable to have children). It must not be given to women who are or might be pregnant in the next three months as it can cause congenital abnormalities in children. Cyclophosphamide is increasingly being replaced by mycophenolate mofetil for treating kidney and some other severe manifestations of lupus that cannot be controlled with low dose steroids, hydroxychloroquine and azathioprine. Mycophenolate mofetil does not cause infertility but it can cause congenital abnormalities so it should not be given to lupus patients that are or might become pregnant in the next three months. Other drugs Other drugs that are less frequently used in lupus include intravenous immunoglobulin (often used when the platelets are low) and ciclosporin A, a drug widely used in transplantation medicine to suppress rejection that is useful for patients with low white cells or platelets due to lupus. For very severe skin disease in patients where pregnancy is not a consideration, thalidomide may be considered. Non-lupus drugs Various medications have helped improve the long term outcome in lupus, such as tablets to control blood pressure, anticoagulants (aspirin or warfarin) in those patients with an increased tendency to clotting, and anti-epileptic medication. Skin creams that may be used include corticosteroid and sun-protection creams. Patients who have received long-term steroids are at increased risk from osteroporosis, so calcium and vitamin D3 preparations are often recommended. Other drugs for the prevention and treatment of osteoporotic fractures may be advised in those not planning pregnancy (e.g. bisphosphonates). Finally HRT (hormone replacement therapy) and the Pill. It is now recognised that those women with antiphospholipid antibodies are at increased risk of thrombosis or migraine when taking contraception containing oestrogen, so

progesterone only contraception may be advised. Hormone replacement therapy containing oestrogen used to be given to treat osteoporosis in post menopausal lupus patients, but it is no longer recommended for use long term due to increased risk of heart attacks. Taking your Medication In order for a medicine to be effective it must reach a particular concentration in the blood and/or tissues, e.g. skin, joints, kidneys, etc. and therefore it is important to take a medicine regularly at the prescribed dose and frequency in order to attain and maintain this effective concentration. Moreover, as different medicines exert their effects in different ways in the body, the time taken to achieve a notable benefit will vary from days to several months! For people with chronic diseases, such as lupus, it is tempting to give up on medicine if the hoped for benefits are not seen quickly, but it is best to be patient and to persevere according to the prescriber s advice. Drugs should not be stopped just because you feel better either, as many drugs are used to help prevent problems in the future, as well as to treat current symptoms. It can be hard to distinguish side effects of the disease from side-effects of the drug, so always reduce drugs as recommended by your doctor or nurse and discuss any concerns that you might have before changing your treatment. Anyone unclear or dissatisfied with any aspect of their medication, or concerned about meeting the cost of drugs prescribed for them, should discuss this with their doctor, nurse or pharmacist.

The LUPUS UK Range of Factsheets A range of factsheets are available as follows: 1. LUPUS Incidence within the Community 2. LUPUS A Guide for Patients 3. LUPUS The Symptoms and Diagnosis 4. LUPUS The Joints and Muscles 5. LUPUS The Skin and Hair 6. LUPUS Fatigue and your Lifestyle 7. LUPUS and Pregnancy 8. LUPUS and Blood Disorders 9. LUPUS and Medication 10. LUPUS and the Kidneys 11. LUPUS and Associated Conditions 12. LUPUS and the Brain 13. LUPUS The Heart and Lungs 14. LUPUS The Mouth, Nose and Eyes 15. LUPUS and Light Sensitivity 16. LUPUS and the Feet 17. LUPUS and Men 18. LUPUS and Mixed Connective Tissue Disease LUPUS UK is the registered national charity caring for people with lupus and has over 5,500 members who are supported by the Regional Groups. LUPUS UK acknowledges with gratitude the assistance of Professor Caroline Gordon and colleagues (Queen Elizabeth Hospital, Birmingham) in the provision of clinical information towards the production of these factsheets. LUPUS UK also thanks the Wooler Walkers (Northumberland) for their valued sponsorship towards the cost of producing the factsheets. Please contact our National Office should you require further information about the sources used in the production of this factsheet or for further information about lupus. LUPUS UK will be pleased to provide a booklist and details of membership. St James House, Eastern Road, Romford, Essex RM1 3NH Tel: 01708 731251 www.lupusuk.org.uk Reg. Charity nos. 1051610, SC039682 5k RW 9/15